20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters

TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome

(2011) Miriam L. Hoven-Gondrie et al.   JOURNAL OF SURGICAL ONCOLOGY

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

(2010) Carlo Riccardo Rossi et al.   ANNALS OF SURGICAL ONCOLOGY

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Surgery and radiotherapy in the treatment of cutaneous melanoma

(2009) A. Testori et al.   ANNALS OF ONCOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of Factors Influencing Outcome in Patients With In-Transit Malignant Melanoma Undergoing Isolated Limb Perfusion Using Modern Treatment Parameters

(2009) H. Richard Alexander et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience

(2008) Hidde M. Kroon et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases

(2008) Nanda Kandamany et al.   LASERS IN MEDICAL SCIENCE

Electrochemotherapy in treatment of tumours

(2007) G. Sersa et al.   EJSO